NASDAQ:OVID
Ovid Therapeutics Inc Stock News
$3.15
-0.125 (-3.82%)
At Close: May 17, 2024
Is Ovid Therapeutics Inc. (OVID) Going to Burn These Hedge Funds?
01:20am, Thursday, 09'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners
12:00am, Wednesday, 08'th Jul 2020
Takeda and the New York Academy of Sciences announced today the Winners of the third annual Innovators in Science Award.
IPO Update: Nkarta Proposes Terms For $150 Million IPO (Pending:NKTX)
04:05pm, Sunday, 05'th Jul 2020
Nkarta has filed to raise $150 million in an IPO. The firm is advancing a pipeline of drug candidates for blood and other cancer indications. NKTX has shown pro
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), today announced it will join the Exelixis and Roche clinical collaboration and participate in the
Global Type 1 Diabetes Market Will Reach USD 2,800 Million by 2026: Facts & Factors
01:13pm, Wednesday, 01'st Jul 2020
Global type 1 diabetes market is expected to grow above a CAGR of 5.0% and is anticipated to reach over USD 2,800 Million by 2026.
Biotech firm Carmine Therapeutics inks US$900m deal with Takeda Pharmaceuticals
11:00pm, Tuesday, 30'th Jun 2020
CARMINE Therapeutics, a biotech firm developing non-viral gene therapies for rare diseases, on Wednesday said it has signed a US$900 million research agreement with Takeda Pharmaceutical to discover,
Local gene therapy firm inks $1.2b deal with pharma giant
09:00pm, Tuesday, 30'th Jun 2020
A local gene therapy start-up has clinched a deal worth more than $1.2 billion with a global pharmaceutical giant to develop and eventually commercialise its treatments for rare genetic diseases.. Rea
Singapore gene therapy start-up clinches deal of over S$1.2b with global pharmaceutical giant
03:17pm, Tuesday, 30'th Jun 2020
[SINGAPORE] A local gene therapy start-up has clinched a deal of more than S$1.2 billion with a global pharmaceutical giant to develop and eventually commercialise its treatments for rare genetic dise
Singapore gene therapy start-up clinches deal of over $1.2b with global pharmaceutical giant
11:00am, Tuesday, 30'th Jun 2020
SINGAPORE - A local gene therapy start-up has clinched a deal of more than $1.2 billion with a global pharmaceutical giant to develop and eventually commercialise its treatments for rare genetic disea
Xconomy: Roche Gets FDA OK for Injectable Version of Breast Cancer Drug
02:07am, Tuesday, 30'th Jun 2020
A new version of a combination drug marketed by Roche for early-stage and metastatic breast cancer with a specific genetic signature received FDA approval
El farmacéutico sueco, Novartis (SWX: NOVN), dijo la semana pasada que ya no buscará la aprobación europea para Xiidra (droga de ojo seco). Según Takeda Pharmaceutical (TYO: 4502), se espera que l
Il produttore svedese di farmaci, Novartis (SWX: NOVN), ha detto la scorsa settimana che non chiederà più l’approvazione europea per lo Xiidra (farmaco contro la secchezza oculare). Secondo Takeda
Takeda estimates £162.50 million hit to operating loss as Novartis withdraws from European approval for Xiidra | Invezz
02:25pm, Monday, 29'th Jun 2020
Swedish drugmaker, Novartis (SWX: NOVN), said last week that it will no longer seek European approval for Xiidra (dry-eye drug). According to Takeda Pharmaceutical (TYO: 4502), Novartis decision is ex
